Eternygen holds first closing of its Series A2 funding round
Eternygen has held first closing of its Series A2 funding round led by new anchor investor Evotec SE and additional funding from venture capital firms Epidarex Capital, IBB Ventures and a number of family offices. The new investment amounting to EUR5 million will be used to drive Eternygen’s development of novel